Psychedelic experiences, trauma and integration

Psychotherapy, integration and reflection around psychedelic or altered-state experiences

Last reviewed: October 2026

Psychedelic and other altered-state experiences can leave people with emotions, bodily sensations, memories, insights or changes in perspective that are difficult to place.

Some experiences feel meaningful or helpful. Others are confusing, frightening or unfinished. Earlier trauma, grief, shame, relational patterns or existential questions may also become more accessible.

I offer a therapeutic space in which to explore what has been stirred, what it may mean, and what may need attention afterwards.

A powerful experience may bring something important into awareness, but access, processing and integration are not the same thing. What becomes accessible relatively quickly may take considerably longer to understand, process and incorporate into ordinary life.

 

Current scope of my practice

My role is psychotherapeutic: helping people explore meaning, trauma responses, regulation, relationships and integration following psychedelic or altered-state experiences.

The experience may have been self-directed, informally supported, facilitated or ceremonial, or have taken place within a structured research or clinical setting. In each case, my involvement is with what is subsequently brought into psychotherapy rather than with administering or facilitating the psychedelic experience itself.

At present, I do not offer or facilitate psychedelic-assisted therapy through my UK private practice.

I do not:

  • provide or supply psychedelic or other controlled substances;

  • advise on dosing, combinations, methods of administration or substance use;

  • act as a sitter or provide therapeutic monitoring or support during psychedelic dosing sessions;

  • provide clinical supervision for practitioners in the provision, administration or facilitation of psychedelic-assisted therapy, or in unregulated psychedelic treatment or facilitation;

  • provide therapy or therapeutic support while someone is under the influence of a psychedelic or other non-prescribed psychoactive substance;

  • make introductions or referrals to psychedelic-assisted therapy providers, facilitators, retreats, clinical trials or sources of psychedelic substances;

  • plan, facilitate, oversee or support self-directed psychedelic use;

  • provide preparation intended to support planned self-directed or unregulated psychedelic use.

In my work as a clinical supervisor, I may supervise psychotherapy or integration work in which a client’s previous psychedelic experience is clinically relevant. This is distinct from supervising the provision, administration or facilitation of psychedelic-assisted therapy or psychedelic dosing sessions.

I may provide links to publicly available legal, regulatory or research information for general context. These are not recommendations, referrals or guidance about obtaining or using psychedelic substances.

Scope and self-directed psychedelic use

Nothing on this website should be understood as recommending, encouraging or endorsing self-directed, unregulated or unlawful psychedelic use. References to such experiences reflect the fact that psychedelic use occurs outside regulated clinical and research settings, including in circumstances that may be unlawful. They are discussed here because their psychological effects may subsequently become relevant within psychotherapy.

If an experience has already occurred, we can work with what remains afterwards. The work remains psychotherapy.

UK context

In the UK, psychedelic-assisted treatment involving Schedule 1 substances such as psilocybin, LSD or MDMA is not currently available as routine clinical care. Schedule 1 drugs are subject to particularly restrictive controls and ordinarily require a Home Office licence for research or other specifically authorised purposes.

Ketamine has a different legal status and is regulated as a Schedule 2 controlled drug. Schedule 2 substances can be used medically within the appropriate legal and clinical framework, although they remain subject to controls concerning prescribing, possession, supply and record-keeping.

The schedules concern how controlled drugs may lawfully be accessed and used; they are not simply a ranking of how dangerous one substance is compared with another.

This legal and regulatory context can change, so the information and official sources linked below are reviewed periodically.

Why integration may matter

A psychedelic or altered-state experience may make an emotion, memory, bodily response, relational pattern or new perspective more accessible.

Greater access does not necessarily mean that something has been psychologically processed, and processing does not necessarily mean that it has become integrated into relationships, behaviour or everyday life.

Integration concerns what happens afterwards: how the experience is understood, what remains emotionally or bodily active, how it relates to the person's wider history and relationships, and what becomes sustainable over time.

It does not require every insight to be preserved, every interpretation to be accepted, or everything that emerged to be acted upon. Some experiences become more meaningful with reflection, while other interpretations may change as they are considered in the context of ordinary life.

When an interest in psychedelics arises in therapy

An interest in psychedelics can itself become relevant therapeutic material without the work becoming preparation for psychedelic use.

We might explore what the person hopes will change, what currently feels unavailable or difficult, and what they imagine a psychedelic experience might provide. It may also be useful to consider whether the wish is expressing something about the therapy itself—for example, a sense that something important is not yet being reached, felt, understood or able to move.

This can include considering what they fear may not happen through the existing therapeutic process, whether anything in the work may need to be approached differently, and whether these themes are also appearing within the therapeutic relationship.

Expectations can also be considered in context. Media coverage, research headlines, personal accounts and wider cultural narratives may sometimes contribute to idealised or simplified expectations of what psychedelic experiences can achieve. Exploring these influences can help distinguish the person's own hopes and needs from expectations that may have developed around the broader cultural presentation of psychedelics.

This work may be helpful if

You have had a psychedelic or altered-state experience and:

  • you are finding it difficult to settle, understand or put into words;

  • memories, images, bodily responses, fear, shame, grief or other trauma-related material have emerged;

  • an insight felt important but you are unsure what to do with it;

  • the experience felt joyful, connecting or deeply meaningful and you want to consider what you wish to carry forward;

  • you feel more open, sensitive, confused or unsettled than you expected;

  • you are experiencing anxiety, derealisation, depersonalisation, sleep disruption or difficulty returning to ordinary life;

  • you are trying to distinguish insight from urgency, idealisation, avoidance or impulsive decision-making;

  • something emerged that felt too overwhelming to remain with;

  • you are uncertain how much confidence to place in a memory, image, belief or interpretation;

  • the experience appears to have affected psychotherapy already underway;

  • you want to explore what happened without it being either romanticised or dismissed.

Meaning, memory and certainty

Altered states can give memories, images, beliefs and interpretations an unusually strong sense of significance or certainty.

That significance can be taken seriously without assuming that every interpretation is factually accurate. Psychological meaning and historical certainty are different questions.

Where autobiographical or trauma-related material emerges, I aim to work without leading or suggestive interpretation. We can explore how the experience connects with your history, body, relationships and present circumstances while leaving appropriate room for uncertainty.

The aim is not necessarily to establish certainty quickly, but to develop a more grounded understanding over time.

Beginning therapy

We would usually begin with an initial consultation to consider:

  • what has brought you to therapy;

  • what happened during and after the experience;

  • what you hope to understand or integrate;

  • how you are functioning now, including sleep, work or study and relationships;

  • whether trauma or dissociative responses appear to have been activated;

  • how settled or unsettled you currently feel;

  • what support you already have;

  • where relevant, what substance was involved, when the experience occurred, whether prescribed medication or other substances were involved, and what effects have continued afterwards;

  • whether psychotherapy with me is the appropriate form and level of support.

Asking about the substance and the circumstances of the experience does not mean that I will advise you about its use. It helps me understand what happened and whether another form of assessment or support may also be appropriate.

Integration may become part of ongoing psychotherapy or, in some circumstances, a shorter period of more focused work.

The initial task may also be determining whether medical, psychiatric, addiction or another specialist form of support is needed before or alongside psychotherapy.

Book a free 20-minute therapy consultation

Understanding psychedelic experiences and integration

The sections below provide some further context about how psychedelic and altered-state experiences may interact with trauma, the body, relationships, meaning and psychotherapy.

Open any section that seems relevant to you.

  • Not every psychedelic experience is best understood through a trauma framework.

    Some experiences are primarily joyful, spiritual, embodied, creative, relational, existential or difficult to classify.

    For people with trauma histories, however, earlier experiences of threat, neglect, attachment injury, loss or shame may become more accessible. This can occur through memories or images, but also through fear, grief, bodily contraction, numbness, collapse, anger or a less clearly defined sense that something emotionally significant has been touched.

    The emergence of traumatic material does not establish that it was processed during the experience.

    If someone remains overwhelmed, highly activated or dissociated afterwards, the immediate therapeutic work may involve orientation, sleep, regulation and restoring a greater sense of safety and agency before exploring the material further.

    Pacing is particularly important when material has become accessible more rapidly than the person can assimilate it. The intensity of an experience alone does not indicate how much therapeutic change has occurred.

  • Integration is not solely cognitive. Someone may understand an experience intellectually while their body continues to respond as though something remains unresolved.

    Following an altered-state experience, some people notice heightened sensitivity, tension, exhaustion, activation, unusual sensations, dissociation or changes in their sense of self or surroundings.

    Therapy may therefore include attention to:

    • bodily sensations and impulses;

    • activation and settling;

    • orientation to the present;

    • tension, collapse, mobilisation or withdrawal;

    • dissociation or disconnection;

    • the capacity to remain present with emotion;

    • relationships between bodily experience, meaning and relationship.

    Depending on the person and the formulation, I may draw on relational psychotherapy, Sensorimotor Psychotherapy, Deep Brain Reorienting, parts-informed work and other approaches from my wider psychotherapy practice.

    These are not psychedelic protocols.

  • Altered-state experiences can affect how someone understands themselves and other people. Feelings of closeness, grief, anger, love, loneliness, forgiveness, fear, dependence, separation or belonging may become more prominent.

    Sometimes an experience also creates a strong sense that a relationship or another significant aspect of life needs to change.

    It can be useful to take an insight seriously while allowing time to consider it in the context of ordinary experience. This may be particularly relevant before major decisions concerning relationships, work, identity, family or other important areas of life.

  • Integration is not limited to difficult experiences.

    Some people seek psychotherapy after an experience that felt profoundly positive and may have involved connection, compassion, unity, beauty, spiritual significance or a changed relationship with themselves.

    Such experiences do not need to be reduced to symptoms, nor do their interpretations need to be regarded as unquestionable.

    Therapy can provide space to consider what happened, what meaning the person gives it, and whether aspects of the experience have a place in everyday life.

  • Some experiences are frightening, confusing or difficult to assimilate.

    Afterwards, a person may experience:

    • anxiety or panic;

    • unusual bodily sensations;

    • intrusive images or memories;

    • emotional flooding;

    • derealisation or depersonalisation;

    • heightened sensitivity;

    • sleep disturbance;

    • shame or fear about what occurred;

    • existential uncertainty;

    • changes in identity or self-experience;

    • difficulty reconnecting with ordinary responsibilities or relationships.

    Therapy does not require an immediate judgement about whether the experience was fundamentally “good” or “bad”. The initial task is usually to understand what is happening now and what form of support is appropriate.

    For some people this may involve exploring meaning. For others, restoring regulation and everyday functioning may need greater attention initially.

  • Someone already in psychotherapy may have a psychedelic experience outside my involvement, whether self-directed, supported or facilitated elsewhere, or within a research or other structured setting.

    If this happens, I encourage openness about it.

    Psychedelics can affect mood, sleep, regulation, dissociation, bodily experience, memory, relationships and emotional accessibility, and may therefore also affect the therapeutic process.

    Without knowing about the experience, changes may be attributed entirely to psychotherapy when several processes are involved. The reverse is also possible: changes already developing through therapy may subsequently be attributed solely to the psychedelic experience.

    It may not be possible to determine immediately what has contributed to a particular change. Attention to timing, functioning, relationships, bodily state and the evolving therapeutic process can be more useful than reaching premature conclusions about causation.

  • I encourage clients to tell me if a significant psychedelic or altered-state experience has occurred while we are working together.

    This is clinically relevant information, not a request for permission or approval.

    It can help us understand changes in regulation, sleep, dissociation, mood, bodily experience and the pace or direction of therapy.

    If discussing the experience feels difficult, that can itself be explored. Someone may anticipate judgement, fear a loss of autonomy, feel ashamed or simply be uncertain whether the experience belongs in therapy.

    The purpose of openness is to understand the therapeutic process more accurately.

  • I do not regard psychedelic integration as a single technique or protocol, and there is not currently one established model of integration psychotherapy known to be appropriate for everyone.

    I therefore approach this work as psychotherapy: relational, formulation-led, trauma-informed, attentive to bodily experience and responsive to the individual person.

    My primary therapeutic orientation is relational psychotherapy. Depending on the person and what has emerged, my work may also be informed by:

    • Transactional Analysis and relational/psychodynamic thinking;

    • developmental and attachment perspectives;

    • Sensorimotor Psychotherapy;

    • Deep Brain Reorienting;

    • parts-informed approaches;

    • EMDR-informed thinking;

    • neuroscience and nervous-system regulation;

    • neurotype, temperament, learning and sensory differences.

    The fact that a psychedelic experience occurred does not mean that everything that follows should be understood through a psychedelic lens.

    The person's history, relationships, developmental experience, body, temperament, neurotype, resources and current circumstances continue to matter. The psychedelic experience becomes one part of the formulation rather than the whole of it.

  • Psychedelic experiences can occur in very different settings, from self-directed or informally supported use to facilitated, research or clinical contexts. These settings differ in the degree of preparation, screening, support and follow-up they provide.

    What therapy adds is an ongoing relationship in which the experience can be revisited, connected with the person's wider history and current life, and understood over time.

    The therapeutic relationship can provide containment, perspective and a place to explore what feels meaningful, confusing or unresolved. It can also help someone consider an insight without having to accept it immediately, and notice how the experience is affecting relationships, identity, behaviour or the course of therapy itself.

    Integration is therefore not only about making sense of the experience, but about what becomes possible through sustained therapeutic reflection and relationship afterwards.

    The therapist's role is not to determine what the experience means, but to help the person explore it thoughtfully while preserving agency, curiosity and room for uncertainty.

  • Many psychedelic experiences take place outside regulated research and clinical environments.

    Some people describe these experiences as beneficial, while others encounter difficulties they did not anticipate. Findings from controlled research cannot automatically be assumed to apply to other settings.

    Research studies commonly include screening, preparation, controlled conditions, structured support and follow-up. Safety findings need to be understood in relation to those conditions.

    Screening may include psychological history, current stability, physical health, medication, other substance use and personal or family history. Some of these areas require medical or psychiatric expertise rather than psychotherapy alone.

    Relational conditions also matter. Altered states may involve increased emotional openness, vulnerability, uncertainty and suggestibility, so the competence, boundaries, motivations and behaviour of anyone occupying a helping role can be important.

    Having a friend, sitter, guide or facilitator present is not equivalent to professional assessment or clinical care. At the same time, the fact that an experience occurs outside a regulated setting does not mean that it will necessarily be harmful.

    Self-directed, informally supported, facilitated and formally researched experiences should not be treated as interchangeable.

    If an interest in psychedelics develops from psychological distress or a wish for change, that interest can itself become meaningful material for psychotherapy. We can explore what the person hopes might change, what feels unavailable at present, and what they imagine an altered-state experience might make possible.

    Those questions can be considered without turning psychotherapy into preparation for psychedelic use.

    Within my practice, I do not assess people for the purpose of self-directed psychedelic use, advise them how to undertake it, prepare someone for a planned psychedelic session, supervise substance use or refer to psychedelic facilitators.

  • I do not assume that psychedelic experiences are inherently healing or inherently harmful.

    They may be meaningful, helpful, confusing, frightening, destabilising or difficult to interpret, and these possibilities are not mutually exclusive.

    Research into psychedelics continues to develop, while important questions remain about who may benefit, who may be vulnerable to harm, how longer-term change occurs, and how findings from controlled research translate into other contexts.

    My approach is therefore one of openness combined with appropriate caution.

    In particular, I do not assume that:

    • intensity demonstrates therapeutic depth;

    • emotional release means that trauma has been resolved;

    • unusual experiences have one correct interpretation;

    • apparent memories should automatically be taken literally;

    • spiritual experiences need to be either pathologised or confirmed;

    • sudden insight should determine major life decisions;

    • psychedelic experiences replace slower developmental, relational and embodied processes of change.

    A significant altered-state experience can be explored seriously without requiring it to become the explanation for everything that follows.

A longer reflection

If you would like to explore these themes in greater depth, you can read:

Psychedelic experiences and integration: when something opens too quickly ›

The article considers in more detail trauma and bodily experience, access and integration, meaning and memory, relationships, different contexts of psychedelic experience, and what can happen when psychedelic experiences overlap with ongoing psychotherapy.

When integration psychotherapy may not be the right starting point

Integration psychotherapy is not a substitute for emergency, medical, psychiatric, addiction, safeguarding or crisis support.

When urgent support may be needed

Urgent or emergency assessment may be more appropriate if you:

  • feel unable to keep yourself safe;

  • are at immediate risk of harming yourself or someone else;

  • are severely confused or disorientated;

  • appear to be losing contact with ordinary reality in a way that compromises safety;

  • are experiencing severe or rapidly worsening dissociation that affects orientation, safety or everyday functioning;

  • are experiencing dangerous or concerning physical symptoms.

If you need urgent help now, feel unable to keep yourself safe, or require crisis support, please use urgent or emergency services rather than waiting for a therapy appointment.

Useful helplines and websites ›

When additional medical or psychiatric assessment may be important

Some situations may not be immediate emergencies but can still require medical, psychiatric, addiction or another specialist assessment before or alongside psychotherapy.

These may include:

  • substantial or prolonged sleep disruption;

  • marked or sustained changes in mood, energy, activity or behaviour;

  • persistent perceptual changes;

  • significant derealisation or depersonalisation that is not settling;

  • increasing paranoia, confusion or difficulty distinguishing internal experience from external events;

  • deterioration in everyday functioning;

  • substance use that is becoming difficult to control;

  • physical or psychological symptoms that remain concerning or are worsening.

If psychotherapy with me does not appear safe or sufficient at that point, I may suggest contacting your GP, NHS mental health services, an addiction service or another appropriately qualified medical or mental health professional.

This is different from referring someone for psychedelic-assisted therapy, a facilitator, retreat, clinical trial or access to substances, which I do not provide.

Training and continuing professional development

My work with people following psychedelic experiences sits within my established psychotherapy practice.

I am currently undertaking specialist professional training in psychedelic-assisted therapy and altered states as part of my continuing professional development. This informs my developing understanding of integration, trauma, safety, suggestibility, ethics and the emerging clinical and research literature.

It does not change the scope of my UK private practice. I do not currently provide psychedelic-assisted therapy, dosing sessions, preparation for planned psychedelic use, sitting, facilitation or referrals to psychedelic providers.

Related pages

Individual therapy ›
For a broader description of individual psychotherapy and who it may suit.

Trauma-focused individual psychotherapy ›
For more about carefully paced work with trauma, dissociation, and nervous-system responses.

Neurofeedback ›
For information about in-person neurofeedback where regulation, sleep, overwhelm, or reactivity are central.

Useful helplines and websites ›
For urgent, crisis, medical, safeguarding, and specialist support outside my practice.

 

If you would like to explore working together

You are welcome to book a free 20-minute consultation.

We can talk about what happened, what you are looking for, and whether psychotherapy may be an appropriate form of support.

If psychotherapy with me does not appear appropriate, I will say so clearly and, where relevant, suggest that you contact an appropriate medical, psychiatric, addiction, crisis, safeguarding or other regulated service.

I do not provide referrals or introductions for psychedelic-assisted therapy, facilitators, retreats, clinical trials or access to substances.

There is no pressure to continue.

Book a free 20-minute therapy consultation